Tumors of the Cervix

Textbook of Uncommon Cancer, Third Edition

Volumn , Issue , 2006, Pages 501-520

  Tewari, Krishnansu S ^a   Monk, Bradley J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical cancer; Histology; History; Immunocompromise; Pregnancy; Suboptimal surgery

Indexed keywords

EID: 77952250515     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470030542.ch45     Document Type: Chapter

References (97)

1. Freund AW. Zu meiner methode der total uterus extirpation. Zbl Gynaek 1878; 2: 265.
2. Clark JG. A more radical method for performing hysterectomy for cancer of the uterus. Bull Johns Hopkins Hosp 1895; 6: 120.
3. Schauta F. Die Erweiterte Vaginale Totalexstirpation des Uterus bei Kollumkarzinom. Wien, Leipzig, Germany: Josef Safar, 1908.
4. Wertheim E. The extended abdominal operation for carcinoma uteri (based on 500 operative cases). Am J Obstet Gynecol 1912; 66: 169.
5. Roentgen WC. On a new kind of rays. Nature 1896; 53: 274-6.
6. Curie P, Curie MS, Bémont G. On a new, strongly radioactive substance, contained in pitchblende. C R Acad Sci Paris 1898; 127: 1215-7.
7. Pasteau O, Degrais P. The radium treatment of cancer of the prostate. Rev Mal Nutr 1911; 10: 363-7.
8. Taussig FJ. Iliac lymphadenectomy with irradiation in the treatment of cancer of the cervix. Am J Obstet Gynecol 1934; 28: 650-2.
9. Meigs JV. Radical hysterectomy with bilateral node dissection. A report of 100 patients operated five or more years ago. Am J Obstet Gynecol 1951; 62: 854.
10. Okabayashi H. Radical abdominal hysterectomy for cancer of the cervix uteri. Surg Gynecol Obstet 1921; 33: 335-41.
11. Brunschwig A. Complete excision of pelvic viscera for advanced cancer. Cancer 1948; 1: 177.
12. Papanicoloau GN, Trout HF. Diagnosis of Uterine Cancer by Vaginal Smears. New York: The Commonwealth Fund, 1943.
13. Gey GO, Coffman WD, Kubicek MT. Tissue culture studies of the proliferative capacity of cervical carcinoma and normal epithelium. Cancer Res 1952; 12: 264-5.
14. Durst M, et al. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 1983; 80: 3812-5.
15. Boshart M, et al. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 1984; 3: 1151-7.
16. Degefu S, et al. Verrucous carcinoma of the cervix: a report of two cases and literature review. Gynecol Oncol 1986; 25: 37-47.
17. Ng WK, Cheung LK, Li AS. Warty (condylomatous) carcinoma of the cervix. A review of 3 cases with emphasis on thin-layer cytology and molecular analysis for HPV. Acta Cytol 2003; 47: 159-66.
18. Koenig C, et al. Papillary squamotransitional cell carcinoma of the cervix: a report of 32 cases. Am J Surg Pathol 1997; 21: 915-21.
19. Ortega-Gonzalez P, Chanona-Vilchis J, Dominguez-Malagon H. Transitional cell carcinoma of the uterine cervix. A report of six cases with clinical, histologic and cytologic findings. Acta Cytol 2002; 46: 585-90.
20. Bais AG, et al. Lymphoepithelioma-like carcinoma of the uterine cervix: absence of Epstein-Barr virus, but presence of multiple human papillomavirus infection. Gynecol Oncol 2005; 97: 716-8.
21. Tseng CJ, et al. Lymphoepithelioma-like carcinoma of the uterine cervix: association with Epstein-Barr virus and human papillomavirus. Cancer 1997; 80: 91-7.
22. Brown J, et al. Sarcomatoid carcinoma of the cervix. Gynecol Oncol 2003; 90: 23-8.
23. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumors of the cervix. In Kurman RJ (ed) Blaustein's Pathology of the Female Genital Tract, 5th ed. New York: Springer-Verlag, 2002.
24. Konishi I, et al. Mucin leakage into the cervical stroma may increase lymph node metastasis in mucin-producing cervical adenocarcinomas. Cancer 1990; 65: 229-37.
25. Fujiwara H, et al. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors. Cancer 1997; 79: 505-12.
26. Hopkins MP, Morley GW. A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 1991; 77: 912-7.
27. Lea JS, et al. Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival. Gynecol Oncol 2002; 84: 115-9.
28. Young RH, Scully RE. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer 1989; 63: 1773-9.
29. Utsugi K, et al. Clinicopathologic features of villoglandular papillary adenocarcinoma of the uterine cervix. Gynecol Oncol 2004; 92: 64-70.
30. Young RH, Clement PB. Endocervical adenocarcinoma and its variants: their morphology and differential diagnosis. Histopathology 2002; 41: 185-207.
31. Silverberg SG, Hurt WG. Minimal deviation adenocarcinoma ("adenoma malignum") of the cervix: a reappraisal. Am J Obstet Gynecol 1975; 121: 971-5.
32. Hirai Y, et al. A clinicocytopathologic study of adenoma malignum of the uterine cervix. Gynecol Oncol 1998; 70: 219-23.
33. Herbst AL, Anderson D. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. Semin Surg Oncol 1990; 6: 343-6.
34. Reich O, et al. Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol 2000; 76: 331-5.
35. Rose PG, Reale FR. Serous papillary carcinoma of the cervix. Gynecol Oncol 1993; 50: 361-4.
36. Costa MJ, McIlnay KR, Trelford J. Cervical carcinoma with glandular differentiation: histological evaluation predicts disease recurrence in clinical stage I or II patients. Hum Pathol 1995; 26: 829-37.
37. Zhou C, et al. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol 1998; 22: 113-20.
38. Ferry JA, Scully RE. Mesonephric remnants, hyperplasia, and neoplasia in the uterine cervix. A study of 49 cases. Am J Surg Pathol 1990; 14: 1100-11.
39. Hart WR. Symposium part II: special types of adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2002; 21: 327-46.
40. Silver SA, et al. Mesonephric adenocarcinomas of the uterine cervix: a study of 11 cases with immunohistochemical findings. Am J Surg Pathol 2001; 25: 379-87.
41. Look KY, et al. An analysis of cell type in patients with surgically staged stage IB carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1996; 63: 304-11.
42. Farley JH, et al. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma. Cancer 2003; 97: 2196-202.
43. Lea JS, et al. Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. Gynecol Oncol 2003; 91: 558-62.
44. Gray HJ, et al. Glassy cell carcinoma of the cervix revisited. Gynecol Oncol 2002; 85: 274-7.
45. Hopkins MP, Morely GW. Glass cell adenocarcinoma of the uterine cervix. Am J Obstet Gynecol 2004; 190: 67-70.
46. Thelmo WL, et al. Mucoepidermoid carcinoma of uterine cervix stage IB. Long-term follow-up, histochemical and immunohistochemical study. Int J Gynecol Pathol 1990; 9: 316-24.
47. Grayson W, Taylor LF, Cooper K. Adenoid cystic and adenoid basal carcinoma of the uterine cervix: comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin. Am J Surg Pathol 1999; 23: 448-58.
48. Prempree T, Villasanta U, Tang CK. Management of adenoid cystic carcinoma of the uterine cervix (cylindroma): report of six cases and reappraisal of all cases reported in the medical literature. Cancer 1980; 46: 1631-5.
49. King LA, et al. Adenoid cystic carcinoma of the cervix in women under age 40. Gynecol Oncol 1989; 32: 26-30.
50. Brainard JA, Hart WR. Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia. Am J Surg Pathol 1998; 22: 965-75.
51. Viswanathan AN, et al. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 2004; 93: 27-33.
52. Chan JK, et al. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 2003; 97: 568-74.
53. Chang TC, et al. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 1998; 83: 712-8.
54. Hoskins PJ, et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 2003; 21: 3495-501.
55. Albores-Saavedra J, et al. Carcinoid tumors of the uterine cervix. Cancer 1976; 38: 2328-42.
56. Seidel RJ, Steinfeld A. Carcinoid of the cervix: natural history and implications for therapy. Gynecol Oncol 1988; 30: 114-9.
57. Wright JD, et al. Cervical sarcomas: an analysis of incidence and outcome. Gynecol Oncol 2005; 99: 348-51.
58. Clement PB, et al. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus. Int J Gynecol Pathol 1998; 17: 211-22.
59. Bell SW, Kempson RL, Hendrickson MR. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol 1994; 18: 535-8.
60. Ramos P, et al. Mullerian adenosarcoma of the cervix with heterologous elements: report of a case and review of the literature. Gynecol Oncol 2002; 84: 161-6.
61. Toyoshima M, et al. Epithelioid leiomyosarcoma of the uterine cervix: a case report and review of the literature. Gynecol Oncol 2005; 97: 957-60.
62. Brand E, et al. Rhabdomyosarcoma of the uterine cervix. Sarcoma botryoides. Cancer 1987; 60: 1552-60.
63. Behtash N, et al. Embryonal rhabdomyosarcoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 2003; 91: 452-5.
64. Gruessner SE, et al. Management of stage I cervical sarcoma botryoides in childhood and adolescence. Eur J Pediatr 2004; 163: 452-6.
65. Bernak KL, et al. Embryonal rhabdomyosarcoma (sarcoma botryoides) of the cervix presenting as a cervical polyp treated with fertility-sparing surgery and adjuvant chemotherapy. Gynecol Oncol 2004; 95: 243-6.
66. Pathak B, et al. Granulocytic sarcoma presenting as tumors of the cervix. Gynecol Oncol 2005; 98: 493-7.
67. Cantuaria G, et al. Primary malignant melanoma of the uterine cervix: case report and review of the literature. Gynecol Oncol 1999; 75: 170-4.
68. Dursun P, et al. Primary cervical lymphoma: report of two cases and review of the literature. Gynecol Oncol 2005; 98: 484-9.
69. Chan JK, et al. Clinicopathologic features of six cases primary cervical lymphoma. Am J Obstet Gynecol 2005; 193: 866-72.
70. Snijders-Keilholz A, et al. Primitive neuroectodermal tumor of the cervix uteri: a case report-changing concepts of therapy. Gynecol Oncol 2005; 98: 516-9.
71. Roopnarinesingh R, Igoe S, Gillan JE. Choriocarcinoma presenting as a primary lesion of the cervix. Ir Med J 2004; 97: 147-8.
72. Lim SC, et al. Mature teratoma of the uterine cervix with lymphoid hyperplasia. Pathol Int 2003; 53: 327-31.
73. Khoor A, et al. Mature teratoma of the uterine cervix with pulmonary differentiation. Arch Pathol Lab Med 1995; 119: 848-50.
74. Cortes J, et al. Immature teratoma primary of the uterine cervix. First case report. Eur J Gynaecol Oncol 1990; 11: 37-42.
75. Yadav K, et al. Endodermal sinus tumor of cervix-case report. Indian J Cancer 1996; 33: 43-5.
76. Maesta I, et al. Primary non-gestational choriocarcinoma of the uterine cervix: a case report. Gynecol Oncol 2005; 98: 146-50.
77. Diakomanolis E, et al. Laser CO2 conization: a safe mode of treating conservatively microinvasive carcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 2004; 113: 229-33.
78. Dargent D, et al. Laparoscopic vaginal radical trachelectomy. A treatment to preserve the fertility of cervical carcinoma patients. Cancer 2000; 88: 1877-82.
79. Covens A, et al. Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix? Cancer 1999; 86: 2273-9.
80. Roy M, Plante M. Radical vaginal trachelectomy for invasive cervical cancer. J Gynecol Obstet Biol Reprod (Paris) 2000; 29: 279-81.
81. Shepherd JH, Mould T, Oram DH. Radical trachelectomy in early stage carcinoma of the cervix: outcome as judged by recurrence and fertility rates. Br J Obstet Gynaecol 2001; 108: 882-5.
82. Bernardini M, et al. Pregnancy outcomes in patients after radical trachelectomy. Am J Obstet Gynecol 2003; 189: 1378-82.
83. Plante M, et al. Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature. Gynecol Oncol 2004; 94: 614-23.
84. Bali A, et al. Central pelvic recurrence 7 years after radical vaginal trachelectomy. Gynecol Oncol 2005; 96: 854-6.
85. Ungar L, et al. Abdominal radical trachelectomy: A fertility-preserving option for women with early cervical cancer. Br J Obstet Gynaecol 2005; 112: 366-9.
86. Hellstrom AC, Sigurjonson T, Pettersson F. Carcinoma of the cervical stum. The radiumhemmet series 1959-1987. Treatment and prognosis. Acta Obstet Gynecol Scand 2001; 80: 152-7.
87. Leath CA III, et al. The role of radical parametrectomy in the treatment of occult cervical carcinoma after extrafascial hysterectomy. Gynecol Oncol 2004; 92: 215-9.
88. Munstedt K, et al. Consequences of inadvertent suboptimal primary surgery in carcinoma of the uterine cervix. Gynecol Oncol 2004; 94: 515-20.
89. Leath CA III, et al. The impact of aborted radical hysterectomy in patients with cervical carcinoma. Gynecol Oncol 2004; 95: 204-7.
90. Lomalisa P, Smith T, Guidozzi F. Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol Oncol 2000; 77: 460-3.
91. Ozsaran AA, et al. Evaluation of the risk of cervical intraepithelial neoplasia and huyman papillomavirus infection in renal transplant patients receiving immunosuppressive therapy. Eur J Gynaecol Oncol 1999; 20: 127-30.
92. Jonas S, et al. De novo malignancies after liver transplantation using tacrolimus-based protocols or cyclosporine-based quadruple immunosuppression with an interleukin-2 receptor antibody or antithymocyte globulin. Cancer 1997; 80: 1141-50.
93. Hacker NF, et al. Carcinoma of the cervix associated with pregnancy. Obstet Gynecol 1982; 59: 735-46.
94. Duggan B, et al. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol 1993; 82: 598-602.
95. Monk BJ, Montz FJ. Invasive cervical cancer complicating intrauterine pregnancy: treatment with radical hysterectomy. Obstet Gynecol 1992; 80: 199-203.
96. Sood AK, et al. Radiotherapeutic management of cervical carcinoma that complicates pregnancy. Cancer 1997; 80: 1073-8.
97. Tewari K, et al. Neoadjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: a report of two cases and review of issues specific to the management of cervical carcinoma in pregnancy including planned delay of therapy. Cancer 1998; 82: 1529-34.